Le Lézard
Classified in: Health
Subject: PER

Medtelligence Continues Expansion of Educational Strategy Team with Hiring of Industry Expert Megan Clem


FORT WASHINGTON, Pa., July 19, 2019 /PRNewswire-PRWeb/ -- Medtelligence, the industry leader in cardiovascular disease medical education, announces the hiring of Megan Clem as Senior Director of Education Strategy. Clem has extensive experience gained through key positions in biotechnology, pharmaceutical, medical device, and education sectors.

"Having worked globally with physician experts on comprehensive educational programming, Megan brings a level of excellence to Medtelligence that will continue to expand our cardiovascular presence," said Kathleen Wickman, BSN, President of Medtelligence (a GLC company).

Clem's career includes positions in sales, marketing, and education for healthcare companies such as Merck, Genentech, Guidant, theHeart.org, Medscape, and PeerVoice.

ABOUT MEDTELLIGENCE
Medtelligence is an industry leader in cardiovascular disease medical education, offering digital education and live meetings across the globe. Medtelligence is a member of the Global Learning Collaborative (GLC), which also includes Omnia Education, Prova Education, and the Academy for Global Interprofessional Learning & Education (AGILE). GLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. More information on Medtelligence is available at http://www.medtelligence.net.

 

SOURCE Medtelligence


These press releases may also interest you

at 08:45
Zinzino (publ) announces that the company's annual report for 2023 in Swedish is now published on the company's website, zinzino.com. The English version will be published within approximately 45 days. The 2024 Annual General Meeting will be held at...

at 08:38
Empower Community Care, a leading global behavioral health and education organization, is thrilled to announce that it has been honored with the prestigious Pacesetter Award for 2024. Presented annually by the Atlanta Business Chronicle, the...

at 08:35
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor...

at 08:35
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice...

at 08:33
1MD Nutrition, a leading developer of physician-formulated, condition-specific nutritional supplements with key ingredients in therapeutically significant dosages from substantiated, human clinical trials, is now a "Proud Partner" of the...

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...



News published on and distributed by: